Allspring Global Investments
TPTX

Allspring Global Investments’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Allspring Global Investments’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,628
Closed -$122K – 2993
2022
Q2 		$122K Sell
1,628
-553,344
-100% -$24.6M ﹤0.01% 1991
2022
Q1 		$14.9M Sell
554,972
-15,704
-3% -$528K 0.02% 758
2021
Q4 		$27.2M Buy
+570,676
New +$25.5M 0.03% 611

Allspring Global Investments's TPTX Position: Q3 2022 in Review

Allspring Global Investments sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 1,628 shares — an estimated $122K sold.

Allspring Global Investments first reported a position in TPTX in Q4 2021 and held it in 3 quarters. The position peaked at $27.2M in Q4 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Allspring Global Investments reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Allspring Global Investments sold 1,628 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $122K.
  • Allspring Global Investments first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Allspring Global Investments's Turning Point Therapeutics, Inc. Common Stock position peaked at $27.2M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Allspring Global Investments's 13F filing for Q3 2022, filed 26 Oct 2022.